查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1811748

全球败血症诊断市场（2025 年版）

Global Sepsis Diagnostics Market: 2025 Edition
出版日期: | 出版商: Daedal Research | 英文 205 Pages | 订单完成后即时交付

价格

2023年全球脓毒症诊断市场规模为8.354亿美元，预计2029年将达到13.9亿美元。脓毒症诊断是医学研究和医疗保健的关键领域，致力于及时准确地识别脓毒症。败血症是一种由人体对感染的极端反应所引起的危及生命的疾病。如果不及时治疗，这种反应可能导致组织损伤、器官衰竭甚至死亡。未来几年，全球脓毒症诊断市场预计将保持成长势头，这得益于持续改善医疗基础设施、持续的技术进步以及人们对脓毒症认识的提高。尤其是在偏远和服务欠缺地区，就地检验的普及将使资源有限的地区能够及时诊断和治疗，从而进一步推动市场成长。此外，持续专注于研究和创新，以及医疗保健提供者、诊断公司和研究机构之间的策略合作伙伴关係，将有助于下一代诊断工具的开发，确保未来几年市场强劲成长。预计 2024-2029 年预测期内市场复合年增长率约为 9%。

本报告调查并分析了全球败血症诊断市场，提供了各地区市场规模、成长动力和挑战、市场趋势和竞争格局的资讯。

目录

第一章执行摘要

第 2 章 简介

  • 败血症诊断：概述
    • 败血症诊断简介
    • 败血症的症状
  • 败血症诊断细分：概述

第三章 全球市场分析

  • 全球败血症诊断市场：分析
    • 全球败血症诊断市场概览
    • 全球败血症诊断市场规模
    • 全球败血症诊断市场技术（微生物学、分子诊断、免疫检测、流式细胞技术等）
    • 全球败血症诊断市场（依产品划分）（血液培养基、仪器、分析及试剂、软体）
    • 全球败血症诊断市场依方法划分（传统诊断、自动诊断）
    • 全球败血症诊断市场依病原体类型划分（细菌性败血症、霉菌性败血症、其他病原体）
    • 全球败血症诊断市场依检验类型（临床检验、就地检验）划分
    • 全球败血症诊断市场按最终用户（医院、病理学和参考实验室、研究机构等）划分
    • 全球败血症诊断市场按地区划分（北美、欧洲、亚太、拉丁美洲、中东和非洲）
  • 全球败血症诊断市场：技术分析
    • 全球败血症诊断市场（按技术）：概述
    • 全球微生物败血症诊断市场规模
    • 分子败血症诊断的全球市场规模
    • 全球分子败血症诊断市场按类型划分（聚合酵素链锁反应、肽核酸萤光、基于杂合反应组的测试、微阵列）
    • 全球分子败血症诊断市场按类型（价值）划分
    • 免疫检测测定败血症诊断的全球市场规模
    • 流式细胞技术败血症诊断的全球市场规模
    • 其他败血症诊断的全球市场规模
  • 全球败血症诊断市场：产品分析
    • 全球败血症诊断市场（按产品划分）概览
    • 用于败血症诊断的血液培养基的全球市场规模
    • 败血症诊断仪器的全球市场规模
    • 败血症诊断检测试剂的全球市场规模
    • 败血症诊断软体的全球市场规模
  • 全球败血症诊断市场：方法分析
    • 全球败血症诊断市场（依方法论）概述
    • 常规败血症诊断的全球市场规模
    • 自动化败血症诊断的全球市场规模
  • 全球败血症诊断市场：病原体类型分析
    • 全球败血症诊断市场：病原体类型概览
    • 细菌性败血症诊断的全球市场规模
    • 全球真菌性败血症诊断市场规模
    • 其他病原体败血症诊断的全球市场规模
  • 全球败血症诊断市场：测试类型分析
    • 全球败血症诊断市场：按测试类型概述
    • 全球临床检测市场规模
    • 全球照护现场脓毒症诊断检测市场规模
  • 全球败血症诊断市场：最终用户分析
    • 全球败血症诊断市场：最终用户概览
    • 败血症诊断医院的全球市场规模
    • 全球败血症诊断病理学和参考实验室市场规模
    • 败血症诊断实验室及其他的全球市场规模

第四章区域市场分析

  • 北美败血症诊断市场：分析
    • 北美败血症诊断市场概况
    • 北美败血症诊断市场规模
    • 北美败血症诊断市场按地区划分（美国、加拿大、墨西哥）
    • 美国败血症诊断市场规模
    • 美国败血症诊断市场技术（微生物学、分子诊断、免疫检测、流式细胞技术等）
    • 美国败血症诊断市场产品（血液培养基、仪器、分析试剂、软体）
    • 美国败血症诊断市场依方法（传统诊断、自动诊断）
    • 美国败血症诊断市场依病原体类型划分（细菌性败血症、霉菌性败血症、其他病原体）
    • 美国败血症诊断市场依检验类型（临床检验、就地检验）划分
    • 美国败血症诊断市场按最终用户（医院、病理学和参考实验室、研究机构等）划分
    • 加拿大败血症诊断市场规模
    • 墨西哥败血症诊断市场规模
  • 欧洲败血症诊断市场：分析
    • 欧洲败血症诊断市场概况
    • 欧洲败血症诊断市场规模
    • 欧洲败血症诊断市场依地区划分（德国、英国、法国、义大利、西班牙、欧洲其他地区）
    • 德国败血症诊断市场规模
    • 英国败血症诊断市场规模
    • 法国败血症诊断市场规模
    • 义大利败血症诊断市场规模
    • 西班牙败血症诊断市场规模
    • 其他欧洲国家的败血症诊断市场规模
  • 亚太败血症诊断市场分析
    • 亚太败血症诊断市场概览
    • 亚太败血症诊断市场规模
    • 亚太败血症诊断市场依地区划分（中国、日本、印度、亚太其他地区）
    • 中国败血症诊断市场规模
    • 日本败血症诊断市场规模
    • 印度败血症诊断市场规模
    • 其他亚太败血症诊断市场规模
  • 拉丁美洲败血症诊断市场：分析
    • 拉丁美洲败血症诊断市场概述
    • 拉丁美洲败血症诊断市场规模
  • 中东和非洲败血症诊断市场分析
    • 中东和非洲败血症诊断市场概况
    • 中东和非洲败血症诊断市场规模

第五章 COVID-19 的影响

  • COVID-19 对全球败血症诊断市场的影响
  • COVID-19 疫情对全球败血症诊断市场的影响

第六章市场动态

  • 成长动力
    • 老化
    • 医疗费用上涨
    • 政府加强提高人们对败血症的认识
    • 院内感染疾病（HAI）发生率增加
    • 脓毒症患者数量不断增加
    • 增加败血症诊断研究的资金和支持
    • 联盟和伙伴关係的激增
    • 核准和报销政策
  • 任务
    • 自动诊断设备成本高昂
    • 专业技能人才短缺
  • 市场趋势
    • 快速诊断测试的开发
    • 提高照护现场诊断工具的可用性
    • 整合人工智慧和机器学习（ML）
    • 越来越多地使用基于生物标记的诊断方法
    • 败血症诊断的技术进步
    • 电子健康记录 (EHR) 集成

第七章 竞争态势

  • 全球败血症诊断市场：竞争格局
  • 全球败血症诊断市场公司：产品比较

第八章 公司简介

  • BioMerieux SA
  • Abbott Laboratories
  • Danaher Corporation (Beckman Coulter Inc.)
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche Ltd
  • Becton, Dickinson and Company
  • Koninklijke Philips NV
  • Siemens Healthineers AG
  • DiaSorin (Luminex Corporation)
  • Bruker Corporation
  • T2 Biosystems, Inc.
  • Immunexpress, Pty Ltd

The global sepsis diagnostics market was valued at US$835.40 million in 2023. The market value is expected to reach US$1.39 billion by 2029. Sepsis diagnostics is a crucial area of medical research and healthcare, focusing on the timely and accurate identification of sepsis, a life-threatening condition caused by the body's extreme response to infection. This response can lead to tissue damage, organ failure, and death if not promptly treated. In the forthcoming years, the global sepsis diagnostics market is expected to continue its growth trajectory due to the sustained efforts to improve healthcare infrastructure, ongoing technological advancements, and increasing awareness about sepsis. The expanding adoption of point-of-care testing, particularly in remote and underserved areas, will further drive market growth by enabling timely diagnosis and treatment in settings with limited healthcare resources. Additionally, the continued focus on research and innovation, coupled with strategic collaborations between healthcare providers, diagnostic companies, and research institutions, will contribute to the development of next-generation diagnostic tools, ensuring the market's robust expansion in the years to come. The market is expected to grow at a CAGR of approx. 9% during the forecasted period of 2024-2029.

Market Segmentation Analysis:

By Technology: The report provides the bifurcation of the global sepsis diagnostics market based on the technology: Microbiology, Molecular Diagnostics, Immunoassays, Flow Cytometry, and Others. The microbiology segment held the highest share of the market, whereas the molecular diagnostics segment is expected to be the fastest-growing segment in the forecasted period. Microbiology remains a cornerstone in sepsis diagnostics due to its proven efficacy in identifying pathogens responsible for infections. The traditional blood culture method, despite being time-consuming, provides comprehensive data about bacterial strains and their antibiotic susceptibilities, which is crucial for tailoring specific treatments. On the other hand, the demand for molecular diagnostics in sepsis has surged due to its ability to provide rapid and precise pathogen identification directly from clinical samples. Techniques such as polymerase chain reaction (PCR) and next-generation sequencing (NGS) enable the detection of bacterial, viral, and fungal DNA or RNA within a few hours, significantly faster than traditional culture methods. This rapid turnaround is crucial in the early stages of sepsis, where timely intervention can drastically improve patient outcomes.

By Type: The global molecular sepsis diagnostics market can be further divided into four segments based on the type: Polymerase Chain Reaction, Peptide Nucleic Acid-Fluorescent in Situ Hybridization, Syndromic Panel-Based Testing, and Microarrays. The polymerase chain reaction segment held the highest share of the market, whereas the microarrays segment is expected to be the fastest-growing segment in the forecasted period. Microarrays are gaining popularity in the molecular sepsis diagnostics market due to their capability to analyze multiple genetic markers simultaneously, offering a high-throughput approach to pathogen identification and characterization. This technology involves hybridizing patient sample nucleic acids to a chip containing numerous probes, enabling the detection of a wide range of sepsis-related pathogens and resistance genes in a single test.

By Product: The report further provides the segmentation based on the following products: Blood Culture Media, Instruments, Assays & Reagents, and Software. The blood culture media held the highest share of the market, whereas the software segment is expected to be the fastest-growing segment in the forecasted period. The demand for blood culture media in the global sepsis diagnostics market is rising due to its critical role in the initial detection and identification of pathogens responsible for sepsis. Blood culture media are essential for cultivating bacteria, fungi, and other microorganisms from blood samples, which is a fundamental step in diagnosing sepsis. On the other hand, software is becoming increasingly important in the global sepsis diagnostics market due to its role in managing and analyzing complex diagnostic data. Advanced diagnostic software integrates with various diagnostic instruments and systems to streamline data collection, analysis, and reporting. This integration facilitates real-time monitoring of patient data, enabling healthcare providers to make timely and informed decisions.

By Method: The report provides the glimpse of the sepsis diagnostics market based on the following methods: Conventional and Automated. Conventional diagnostics segment held the highest share of the market, whereas automated diagnostics segment is expected to be the fastest-growing segment in the forecasted period. The demand for automated diagnostics in the global sepsis diagnostics market is surging due to the need for efficiency, accuracy, and rapid turnaround in diagnosing sepsis. Automated diagnostic systems, such as automated blood culture systems, molecular diagnostic platforms, and high-throughput assay systems, streamline the diagnostic process by reducing manual intervention, minimizing human error, and accelerating result generation.

By Pathogen Type: The global sepsis diagnostics market can be divided into three segments based on the pathogen type: Bacterial Sepsis, Fungal Sepsis, and Other Pathogen. Bacterial sepsis held the highest share of the market and is expected to be the fastest-growing segment in the forecasted period. Bacterial sepsis is a significant driver of growth in the global sepsis diagnostics market due to its high prevalence and severe impact on patient outcomes. Bacterial infections are among the most common causes of sepsis, resulting from pathogens such as Escherichia coli, Staphylococcus aureus, and Klebsiella pneumoniae. The increasing incidence of bacterial sepsis is driven by factors such as antibiotic resistance, rising rates of chronic diseases, and the prevalence of invasive medical procedures that heighten infection risk.

By Test Type: The global sepsis diagnostics market can be divided into two segments based on the test type: Laboratory Tests and Point-of-Care Tests. Laboratory tests held the highest share in the market, whereas point-of-care tests segment is expected to be the fastest-growing segment in the forecasted period. The demand for point-of-care (POC) tests are surging due to their ability to provide rapid, on-site results that are crucial for timely intervention in sepsis management. POC tests are designed to be used at or near the patient's bedside, offering immediate diagnostic information that facilitates quick decision-making and treatment initiation. This is particularly important in critical care settings where every minute counts. Innovations in POC testing, such as portable molecular diagnostic devices and rapid immunoassays, have improved the accessibility and convenience of sepsis diagnostics.

By End-User: The report provides the glimpse of the global sepsis diagnostics market based on the following end-users: Hospitals, Pathology & Reference Laboratories, and Research Institutes and Others. Hospitals held the highest share of the market, whereas pathology & reference laboratories segment is expected to be the fastest-growing segment in the forecasted period. Pathology and reference laboratories play a vital role in the global sepsis diagnostics market by providing comprehensive and specialized diagnostic services. These laboratories are equipped with advanced technologies and expertise to perform a wide range of diagnostic tests, including blood cultures, molecular assays, and immunoassays. The increasing complexity of sepsis cases, along with the need for precise identification of pathogens and their resistance profiles, drives the demand for sophisticated diagnostic methods offered by these labs.

By Region: The report provides insight into the sepsis diagnostics market based on the regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America held the major share of the market. In the US, Government initiatives, such as the Sepsis Alliance and the Centers for Disease Control and Prevention's (CDC) sepsis awareness programs, have significantly contributed to increasing awareness and early detection of sepsis. Additionally, the National Sepsis Data Trust Initiative (NSDTI) is an independent, consensus-driven initiative that focuses on improving the diagnosis and treatment of sepsis patients and survivors through the creation of a National Sepsis Data Trust. Moreover, the US has a high incidence rate of sepsis, which necessitates the need for effective diagnostic solutions. For example, the CDC reports that over 1.7 million adults in America develop sepsis each year, with around 350,000 fatalities, underscoring the critical demand for efficient diagnostics.

Germany's sepsis diagnostics market is thriving due to its advanced healthcare system, strong research and development capabilities, and significant government and institutional support. Germany has one of the highest healthcare expenditures in Europe, enabling extensive investment in cutting-edge diagnostic technologies. The country's focus on precision medicine and personalized healthcare solutions aligns well with the need for rapid and accurate sepsis diagnostics. Organizations like the German Sepsis Society (Deutsche Sepsis-Gesellschaft, DSG) play a crucial role in raising awareness and improving sepsis outcomes through education and advocacy.

According to the Asia Pacific Sepsis Alliance, the Asia Pacific region is home to 4.6 billion people, which is 60% of the world's population. The estimated national sepsis incidences in this region range from 120 to 1,600 per 100,000, with mortality rates related to sepsis up to 35%, which are much higher than in Western and other high-income countries. Consequently, the Asia Pacific region has a higher burden of sepsis proportional to population, as well as the highest number of patients affected by sepsis globally. Moreover, India is expected to experience robust growth in the sepsis diagnostics market, driven by factors such as a large and diverse population, a high burden of infectious diseases, and significant improvements in healthcare infrastructure.

Market Dynamics:

Growth Drivers: The global sepsis diagnostics market has been growing over the past few years, due to factors such as aging population, rising healthcare expenditure, rising number of sepsis cases, increasing collaboration and partnerships, regulatory approvals and reimbursement policies, growing government initiatives for creating sepsis awareness, increasing incidence of hospital-acquired infections (HAIs), increase in funding and support for sepsis diagnostics research, and many other factors. Infection is the root cause of sepsis. Sepsis mainly occurs in immunocompromised people, such as those taking chemotherapy, having a splenectomy, and suffering from AIDS and chronic illnesses like diabetes. Among several types of infections, Hospital-acquired Infections (HAIs) are the primary cause of morbidity and mortality among hospitalized patients. According to the World Health Organization (WHO), 7 in 100 patients in high-income countries and 15 in low- and middle-income countries acquire at least one HAI during their hospital stay. On average, 1 in 10 affected patients will die from their HAI. Most deaths can be prevented through early diagnosis and appropriate clinical management. Thus, the high incidence rate of sepsis due to HAIs is expected to boost the demand for sepsis diagnostic products, thereby supporting the sepsis diagnostics market growth during the forecast period.

Challenges: However, the market growth would be negatively impacted by various challenges such as high cost of automated diagnostic devices, lack of skilled professionals, etc.

Trends: The market is projected to grow at a fast pace during the forecast period, due to development of rapid diagnostic tests, increasing use of biomarker-based diagnostics, increasing availability of point-of-care diagnostic tools, integration of artificial intelligence (AI) and machine learning (ML), rising technological advancements in sepsis diagnosis, integration of electronic health records (EHR), etc. The development of rapid diagnostic tests and techniques is poised to significantly accelerate the growth of the sepsis diagnostics market in the forthcoming years by drastically reducing the time required to identify sepsis and its causative pathogens. Traditional diagnostic methods often take several days to yield results, leading to delays in treatment and higher mortality rates. In contrast, rapid diagnostic tests, such as those utilizing polymerase chain reaction (PCR) and next-generation sequencing (NGS), can provide results within hours, enabling prompt and precise medical interventions. This swift turnaround is crucial in the management of sepsis, where every hour of delay can significantly impact patient outcomes.

Impact Analysis of COVID-19 and Way Forward:

The COVID-19 pandemic has had a profound impact on the global sepsis diagnostics market. As healthcare systems worldwide were overwhelmed by the influx of COVID-19 patients, the need for rapid and accurate diagnostics became more critical than ever. The similarities in the inflammatory responses of severe COVID-19 and sepsis necessitated the use of sepsis diagnostic tools to distinguish between the two conditions, optimize patient management, and ensure appropriate treatment strategies. This increased demand for sepsis diagnostics during the pandemic significantly boosted market growth and innovation in this sector.

Competitive Landscape:

The global sepsis diagnostics market is consolidated in nature. The key players in the global sepsis diagnostics market are:

BioMerieux SA

Abbott Laboratories

Danaher Corporation (Beckman Coulter Inc.)

Thermo Fisher Scientific Inc.

F. Hoffmann-La Roche Ltd

Becton, Dickinson and Company

Koninklijke Philips NV

Siemens Healthineers AG

DiaSorin (Luminex Corporation)

Bruker Corporation

T2 Biosystems, Inc.

Immunexpress, Pty Ltd.

Table of Contents

1. Executive Summary

2. Introduction

  • 2.1 Sepsis Diagnostics: An Overview
    • 2.1.1 Introduction to Sepsis Diagnostics
    • 2.1.2 Symptoms of Sepsis
  • 2.2 Sepsis Diagnostics Segmentation: An Overview

3. Global Market Analysis

  • 3.1 Global Sepsis Diagnostics Market: An Analysis
    • 3.1.1 Global Sepsis Diagnostics Market: An Overview
    • 3.1.2 Global Sepsis Diagnostics Market by Value
    • 3.1.3 Global Sepsis Diagnostics Market by Technology (Microbiology, Molecular Diagnostics, Immunoassays, Flow Cytometry, and Others)
    • 3.1.4 Global Sepsis Diagnostics Market by Product (Blood Culture Media, Instruments, Assays & Reagents, and Software)
    • 3.1.5 Global Sepsis Diagnostics Market by Method (Conventional Diagnostics and Automated Diagnostics)
    • 3.1.6 Global Sepsis Diagnostics Market by Pathogen Type (Bacterial Sepsis, Fungal Sepsis, and Other Pathogen)
    • 3.1.7 Global Sepsis Diagnostics Market by Test Type (Laboratory Tests and Point-of-Care Tests)
    • 3.1.8 Global Sepsis Diagnostics Market by End-User (Hospitals, Pathology & Reference Laboratories, and Research Institutes and Others)
    • 3.1.9 Global Sepsis Diagnostics Market by Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)
  • 3.2 Global Sepsis Diagnostics Market: Technology Analysis
    • 3.2.1 Global Sepsis Diagnostics Market by Technology: An Overview
    • 3.2.2 Global Microbiology Sepsis Diagnostics Market by Value
    • 3.2.3 Global Molecular Sepsis Diagnostics Market by Value
    • 3.2.4 Global Molecular Sepsis Diagnostics Market by Type (Polymerase Chain Reaction, Peptide Nucleic Acid-Fluorescent in Situ Hybridization, Syndromic Panel-Based Testing, and Microarrays)
    • 3.2.5 Global Molecular Sepsis Diagnostics Market Type by Value
    • 3.2.6 Global Immunoassays Sepsis Diagnostics Market by Value
    • 3.2.7 Global Flow Cytometry Sepsis Diagnostics Market by Value
    • 3.2.8 Global Others Sepsis Diagnostics Market by Value
  • 3.3 Global Sepsis Diagnostics Market: Product Analysis
    • 3.3.1 Global Sepsis Diagnostics Market by Product: An Overview
    • 3.3.2 Global Sepsis Diagnostics Blood Culture Media Market by Value
    • 3.3.3 Global Sepsis Diagnostics Instruments Market by Value
    • 3.3.4 Global Sepsis Diagnostics Assays & Reagents Market by Value
    • 3.3.5 Global Sepsis Diagnostics Software Market by Value
  • 3.4 Global Sepsis Diagnostics Market: Method Analysis
    • 3.4.1 Global Sepsis Diagnostics Market by Method: An Overview
    • 3.4.2 Global Conventional Sepsis Diagnostics Market by Value
    • 3.4.3 Global Automated Sepsis Diagnostics Market by Value
  • 3.5 Global Sepsis Diagnostics Market: Pathogen Type Analysis
    • 3.5.1 Global Sepsis Diagnostics Market by Pathogen Type: An Overview
    • 3.5.2 Global Bacterial Sepsis Diagnostics Market by Value
    • 3.5.3 Global Fungal Sepsis Diagnostics Market by Value
    • 3.5.4 Global Other Pathogen Sepsis Diagnostics Market by Value
  • 3.6 Global Sepsis Diagnostics Market: Test Type Analysis
    • 3.6.1 Global Sepsis Diagnostics Market by Test Type: An Overview
    • 3.6.2 Global Laboratory Sepsis Diagnostics Tests Market by Value
    • 3.6.3 Global Point-of-Care Sepsis Diagnostics Tests Market by Value
  • 3.7 Global Sepsis Diagnostics Market: End-User Analysis
    • 3.7.1 Global Sepsis Diagnostics Market by End-User: An Overview
    • 3.7.2 Global Sepsis Diagnostics Hospitals Market by Value
    • 3.7.3 Global Sepsis Diagnostics Pathology & Reference Laboratories Market by Value
    • 3.7.4 Global Sepsis Diagnostics Research Institutes and Others Market by Value

4. Regional Market Analysis

  • 4.1 North America Sepsis Diagnostics Market: An Analysis
    • 4.1.1 North America Sepsis Diagnostics Market: An Overview
    • 4.1.2 North America Sepsis Diagnostics Market by Value
    • 4.1.3 North America Sepsis Diagnostics Market by Region (The US, Canada, and Mexico)
    • 4.1.4 The US Sepsis Diagnostics Market by Value
    • 4.1.5 The US Sepsis Diagnostics Market by Technology (Microbiology, Molecular Diagnostics, Immunoassays, Flow Cytometry, and Others)
    • 4.1.6 The US Sepsis Diagnostics Market by Product (Blood Culture Media, Instruments, Assays & Reagents, and Software)
    • 4.1.7 The US Sepsis Diagnostics Market by Method (Conventional Diagnostics and Automated Diagnostics)
    • 4.1.8 The US Sepsis Diagnostics Market by Pathogen Type (Bacterial Sepsis, Fungal Sepsis, and Other Pathogen)
    • 4.1.9 The US Sepsis Diagnostics Market by Test Type (Laboratory Tests and Point-of-Care Tests)
    • 4.1.10 The US Sepsis Diagnostics Market by End-User (Hospitals, Pathology & Reference Laboratories, and Research Institutes and Others)
    • 4.1.11 Canada Sepsis Diagnostics Market by Value
    • 4.1.12 Mexico Sepsis Diagnostics Market by Value
  • 4.2 Europe Sepsis Diagnostics Market: An Analysis
    • 4.2.1 Europe Sepsis Diagnostics Market: An Overview
    • 4.2.2 Europe Sepsis Diagnostics Market by Value
    • 4.2.3 Europe Sepsis Diagnostics Market by Region (Germany, The UK, France, Italy, Spain, and Rest of the Europe)
    • 4.2.4 Germany Sepsis Diagnostics Market by Value
    • 4.2.5 The UK Sepsis Diagnostics Market by Value
    • 4.2.6 France Sepsis Diagnostics Market by Value
    • 4.2.7 Italy Sepsis Diagnostics Market by Value
    • 4.2.8 Spain Sepsis Diagnostics Market by Value
    • 4.2.9 Rest of Europe Sepsis Diagnostics Market by Value
  • 4.3 Asia Pacific Sepsis Diagnostics Market: An Analysis
    • 4.3.1 Asia Pacific Sepsis Diagnostics Market: An Overview
    • 4.3.2 Asia Pacific Sepsis Diagnostics Market by Value
    • 4.3.3 Asia Pacific Sepsis Diagnostics Market by Region (China, Japan, India, and Rest of the Asia Pacific)
    • 4.3.4 China Sepsis Diagnostics Market by Value
    • 4.3.5 Japan Sepsis Diagnostics Market by Value
    • 4.3.6 India Sepsis Diagnostics Market by Value
    • 4.3.7 Rest of Asia Pacific Sepsis Diagnostics Market by Value
  • 4.4 Latin America Sepsis Diagnostics Market: An Analysis
    • 4.4.1 Latin America Sepsis Diagnostics Market: An Overview
    • 4.4.2 Latin America Sepsis Diagnostics Market by Value
  • 4.5 Middle East & Africa Sepsis Diagnostics Market: An Analysis
    • 4.5.1 Middle East & Africa Sepsis Diagnostics Market: An Overview
    • 4.5.2 Middle East & Africa Sepsis Diagnostics Market by Value

5. Impact of COVID-19

  • 5.1 Impact of COVID-19 on Global Sepsis Diagnostics Market
  • 5.2 Post COVID-19 Impact on Global Sepsis Diagnostics Market

6. Market Dynamics

  • 6.1 Growth Drivers
    • 6.1.1 Aging Population
    • 6.1.2 Rising Healthcare Expenditure
    • 6.1.3 Growing Government Initiatives for Creating Sepsis Awareness
    • 6.1.4 Increasing Incidence of Hospital-acquired Infections (HAIs)
    • 6.1.5 Rising Number of Sepsis Cases
    • 6.1.6 Increase in Funding and Support for Sepsis Diagnostics Research
    • 6.1.7 Surging Collaboration and Partnerships
    • 6.1.8 Regulatory Approvals and Reimbursement Policies
  • 6.2 Challenges
    • 6.2.1 High Cost of Automated Diagnostic Devices
    • 6.2.2 Lack of Skilled Professionals
  • 6.3 Market Trends
    • 6.3.1 Development of Rapid Diagnostic Tests
    • 6.3.2 Increasing Availability of Point-of-Care Diagnostic Tools
    • 6.3.3 Integration of Artificial Intelligence (AI) and Machine Learning (ML)
    • 6.3.4 Increasing Use of Biomarker-Based Diagnostics
    • 6.3.5 Rising Technological Advancements in Sepsis Diagnosis
    • 6.3.6 Integration of Electronic Health Records (EHR)

7. Competitive Landscape

  • 7.1 Global Sepsis Diagnostics Market: Competitive Landscape
  • 7.2 Global Sepsis Diagnostics Market Players: Product Comparison

8. Company Profiles

  • 8.1 BioMerieux SA
    • 8.1.1 Business Overview
    • 8.1.2 Revenue by Technology and Application
    • 8.1.3 Business Strategy
  • 8.2 Abbott Laboratories
    • 8.2.1 Business Overview
    • 8.2.2 Operating Segments
    • 8.2.3 Business Strategy
  • 8.3 Danaher Corporation (Beckman Coulter Inc.)
    • 8.3.1 Business Overview
    • 8.3.2 Operating Segments
    • 8.3.3 Business Strategy
  • 8.4 Thermo Fisher Scientific Inc.
    • 8.4.1 Business Overview
    • 8.4.2 Operating Segments
    • 8.4.3 Business Strategy
  • 8.5 F. Hoffmann-La Roche Ltd
    • 8.5.1 Business Overview
    • 8.5.2 Sales by Operating Business
    • 8.5.3 Business Strategy
  • 8.6 Becton, Dickinson and Company
    • 8.6.1 Business Overview
    • 8.6.2 Operating Segments
    • 8.6.3 Business Strategy
  • 8.7 Koninklijke Philips NV
    • 8.7.1 Business Overview
    • 8.7.2 Operating Segments
    • 8.7.3 Business Strategy
  • 8.8 Siemens Healthineers AG
    • 8.8.1 Business Overview
    • 8.8.2 Operating Segments
    • 8.8.3 Business Strategy
  • 8.9 DiaSorin (Luminex Corporation)
    • 8.9.1 Business Overview
    • 8.9.2 Operating Segments
    • 8.9.3 Business Strategy
  • 8.10 Bruker Corporation
    • 8.10.1 Business Overview
    • 8.10.2 Operating Segments
    • 8.10.3 Business Strategy
  • 8.11 T2 Biosystems, Inc.
    • 8.11.1 Business Overview
    • 8.11.2 Revenue by Source
    • 8.11.3 Business Strategy
  • 8.12 Immunexpress, Pty Ltd
    • 8.12.1 Business Overview
    • 8.12.2 Business Strategy

List of Tables

  • Table 1: Government Initiatives for Creating Sepsis Awareness
  • Table 2: Global Sepsis Diagnostics Market Players: Product Comparison

List of Figures

  • Figure 1: Symptoms of Sepsis
  • Figure 2: Sepsis Diagnostics Segmentation
  • Figure 3: Global Sepsis Diagnostics Market by Value; 2019-2023 (US$ Million)
  • Figure 4: Global Sepsis Diagnostics Market by Value; 2024-2029 (US$ Billion)
  • Figure 5: Global Sepsis Diagnostics Market by Technology; 2023 (Percentage, %)
  • Figure 6: Global Sepsis Diagnostics Market by Product; 2023 (Percentage, %)
  • Figure 7: Global Sepsis Diagnostics Market by Method; 2023 (Percentage, %)
  • Figure 8: Global Sepsis Diagnostics Market by Pathogen Type; 2023 (Percentage, %)
  • Figure 9: Global Sepsis Diagnostics Market by Test Type; 2023 (Percentage, %)
  • Figure 10: Global Sepsis Diagnostics Market by End-User; 2023 (Percentage, %)
  • Figure 11: Global Sepsis Diagnostics Market by Region; 2023 (Percentage, %)
  • Figure 12: Global Microbiology Sepsis Diagnostics Market by Value; 2019-2023 (US$ Million)
  • Figure 13: Global Microbiology Sepsis Diagnostics Market by Value; 2024-2029 (US$ Million)
  • Figure 14: Global Molecular Sepsis Diagnostics Market by Value; 2019-2023 (US$ Million)
  • Figure 15: Global Molecular Sepsis Diagnostics Market by Value; 2024-2029 (US$ Million)
  • Figure 16: Global Molecular Sepsis Diagnostics Market by Type; 2023 (Percentage, %)
  • Figure 17: Global Molecular Sepsis Diagnostics Market Type by Value; 2019-2023 (US$ Million)
  • Figure 18: Global Molecular Sepsis Diagnostics Market Type by Value; 2024-2029 (US$ Million)
  • Figure 19: Global Immunoassays Sepsis Diagnostics Market by Value; 2019-2023 (US$ Million)
  • Figure 20: Global Immunoassays Sepsis Diagnostics Market by Value; 2024-2029 (US$ Million)
  • Figure 21: Global Flow Cytometry Sepsis Diagnostics Market by Value; 2019-2023 (US$ Million)
  • Figure 22: Global Flow Cytometry Sepsis Diagnostics Market by Value; 2024-2029 (US$ Million)
  • Figure 23: Global Others Sepsis Diagnostics Market by Value; 2019-2023 (US$ Million)
  • Figure 24: Global Others Sepsis Diagnostics Market by Value; 2024-2029 (US$ Million)
  • Figure 25: Global Sepsis Diagnostics Blood Culture Media Market by Value; 2019-2023 (US$ Million)
  • Figure 26: Global Sepsis Diagnostics Blood Culture Media Market by Value; 2024-2029 (US$ Million)
  • Figure 27: Global Sepsis Diagnostics Instruments Market by Value; 2019-2023 (US$ Million)
  • Figure 28: Global Sepsis Diagnostics Instruments Market by Value; 2024-2029 (US$ Million)
  • Figure 29: Global Sepsis Diagnostics Assays & Reagents Market by Value; 2019-2023 (US$ Million)
  • Figure 30: Global Sepsis Diagnostics Assays & Reagents Market by Value; 2024-2029 (US$ Million)
  • Figure 31: Global Sepsis Diagnostics Software Market by Value; 2019-2023 (US$ Million)
  • Figure 32: Global Sepsis Diagnostics Software Market by Value; 2024-2029 (US$ Million)
  • Figure 33: Global Conventional Sepsis Diagnostics Market by Value; 2019-2023 (US$ Million)
  • Figure 34: Global Conventional Sepsis Diagnostics Market by Value; 2024-2029 (US$ Million)
  • Figure 35: Global Automated Sepsis Diagnostics Market by Value; 2019-2023 (US$ Million)
  • Figure 36: Global Automated Sepsis Diagnostics Market by Value; 2024-2029 (US$ Million)
  • Figure 37: Global Bacterial Sepsis Diagnostics Market by Value; 2019-2023 (US$ Million)
  • Figure 38: Global Bacterial Sepsis Diagnostics Market by Value; 2024-2029 (US$ Million)
  • Figure 39: Global Fungal Sepsis Diagnostics Market by Value; 2019-2023 (US$ Million)
  • Figure 40: Global Fungal Sepsis Diagnostics Market by Value; 2024-2029 (US$ Million)
  • Figure 41: Global Other Pathogen Sepsis Diagnostics Market by Value; 2019-2023 (US$ Million)
  • Figure 42: Global Other Pathogen Sepsis Diagnostics Market by Value; 2024-2029 (US$ Million)
  • Figure 43: Global Laboratory Sepsis Diagnostics Tests Market by Value; 2019-2023 (US$ Million)
  • Figure 44: Global Laboratory Sepsis Diagnostics Tests Market by Value; 2024-2029 (US$ Million)
  • Figure 45: Global Point-of-Care Sepsis Diagnostics Tests Market by Value; 2019-2023 (US$ Million)
  • Figure 46: Global Point-of-Care Sepsis Diagnostics Tests Market by Value; 2024-2029 (US$ Million)
  • Figure 47: Global Sepsis Diagnostics Hospitals Market by Value; 2019-2023 (US$ Million)
  • Figure 48: Global Sepsis Diagnostics Hospitals Market by Value; 2024-2029 (US$ Million)
  • Figure 49: Global Sepsis Diagnostics Pathology & Reference Laboratories Market by Value; 2019-2023 (US$ Million)
  • Figure 50: Global Sepsis Diagnostics Pathology & Reference Laboratories Market by Value; 2024-2029 (US$ Million)
  • Figure 51: Global Sepsis Diagnostics Research Institutes and Others Market by Value; 2019-2023 (US$ Million)
  • Figure 52: Global Sepsis Diagnostics Research Institutes and Others Market by Value; 2024-2029 (US$ Million)
  • Figure 53: North America Sepsis Diagnostics Market by Value; 2019-2023 (US$ Million)
  • Figure 54: North America Sepsis Diagnostics Market by Value; 2024-2029 (US$ Million)
  • Figure 55: North America Sepsis Diagnostics Market by Region; 2023 (Percentage, %)
  • Figure 56: The US Sepsis Diagnostics Market by Value; 2019-2023 (US$ Million)
  • Figure 57: The US Sepsis Diagnostics Market by Value; 2024-2029 (US$ Million) Figure 58: The US Sepsis Diagnostics Market by Technology; 2023 (Percentage, %)
  • Figure 59: The US Sepsis Diagnostics Market by Product; 2023 (Percentage, %)
  • Figure 60: The US Sepsis Diagnostics Market by Method; 2023 (Percentage, %)
  • Figure 61: The US Sepsis Diagnostics Market by Pathogen Type; 2023 (Percentage, %)
  • Figure 62: The US Sepsis Diagnostics Market by Test Type; 2023 (Percentage, %)
  • Figure 63: The US Sepsis Diagnostics Market by End-User; 2023 (Percentage, %)
  • Figure 64: Canada Sepsis Diagnostics Market by Value; 2019-2023 (US$ Million)
  • Figure 65: Canada Sepsis Diagnostics Market by Value; 2024-2029 (US$ Million)
  • Figure 66: Mexico Sepsis Diagnostics Market by Value; 2019-2023 (US$ Million)
  • Figure 67: Mexico Sepsis Diagnostics Market by Value; 2024-2029 (US$ Million)
  • Figure 68: Europe Sepsis Diagnostics Market by Value; 2019-2023 (US$ Million)
  • Figure 69: Europe Sepsis Diagnostics Market by Value; 2024-2029 (US$ Million)
  • Figure 70: Europe Sepsis Diagnostics Market by Region; 2023 (Percentage, %)
  • Figure 71: Germany Sepsis Diagnostics Market by Value; 2019-2023 (US$ Million)
  • Figure 72: Germany Sepsis Diagnostics Market by Value; 2024-2029 (US$ Million)
  • Figure 73: The UK Sepsis Diagnostics Market by Value; 2019-2023 (US$ Million)
  • Figure 74: The UK Sepsis Diagnostics Market by Value; 2024-2029 (US$ Million)
  • Figure 75: France Sepsis Diagnostics Market by Value; 2019-2023 (US$ Million)
  • Figure 76: France Sepsis Diagnostics Market by Value; 2024-2029 (US$ Million)
  • Figure 77: Italy Sepsis Diagnostics Market by Value; 2019-2023 (US$ Million)
  • Figure 78: Italy Sepsis Diagnostics Market by Value; 2024-2029 (US$ Million)
  • Figure 79: Spain Sepsis Diagnostics Market by Value; 2019-2023 (US$ Million)
  • Figure 80: Spain Sepsis Diagnostics Market by Value; 2024-2029 (US$ Million)
  • Figure 81: Rest of Europe Sepsis Diagnostics Market by Value; 2019-2023 (US$ Million)
  • Figure 82: Rest of Europe Sepsis Diagnostics Market by Value; 2024-2029 (US$ Million)
  • Figure 83: Asia Pacific Sepsis Diagnostics Market by Value; 2019-2023 (US$ Million)
  • Figure 84: Asia Pacific Sepsis Diagnostics Market by Value; 2024-2029 (US$ Million)
  • Figure 85: Asia Pacific Sepsis Diagnostics Market by Region; 2023 (Percentage, %)
  • Figure 86: China Sepsis Diagnostics Market by Value; 2019-2023 (US$ Million)
  • Figure 87: China Sepsis Diagnostics Market by Value; 2024-2029 (US$ Million)
  • Figure 88: Japan Sepsis Diagnostics Market by Value; 2019-2023 (US$ Million)
  • Figure 89: Japan Sepsis Diagnostics Market by Value; 2024-2029 (US$ Million)
  • Figure 90: India Sepsis Diagnostics Market by Value; 2019-2023 (US$ Million)
  • Figure 91: India Sepsis Diagnostics Market by Value; 2024-2029 (US$ Million)
  • Figure 92: Rest of Asia Pacific Sepsis Diagnostics Market by Value; 2019-2023 (US$ Million)
  • Figure 93: Rest of Asia Pacific Sepsis Diagnostics Market by Value; 2024-2029 (US$ Million)
  • Figure 94: Latin America Sepsis Diagnostics Market by Value; 2019-2023 (US$ Million)
  • Figure 95: Latin America Sepsis Diagnostics Market by Value; 2024-2029 (US$ Million)
  • Figure 96: Middle East & Africa Sepsis Diagnostics Market by Value; 2019-2023 (US$ Million)
  • Figure 97: Middle East & Africa Sepsis Diagnostics Market by Value; 2024-2029 (US$ Million)
  • Figure 98: Global Percentage of Population Aged 65 Years or Above; 2018-2023 (Percentage, %)
  • Figure 99: Global Healthcare Expenditure as a Share of GDP; 2018-2023 (Percentage, %)
  • Figure 100: BioMerieux SA Revenue by Technology and Application; 2023 (Percentage, %)
  • Figure 101: Abbott Laboratories Revenue by Segment; 2023 (Percentage, %)
  • Figure 102: Danaher Corporation Revenue by Segment; 2023 (Percentage, %)
  • Figure 103: Thermo Fisher Scientific Inc. Revenue by Segment; 2023 (Percentage, %)
  • Figure 104: F. Hoffmann-La Roche Ltd Sales by Operating Business; 2023 (Percentage, %)
  • Figure 105: Becton, Dickinson and Company Revenues by Segment; 2023 (Percentage, %)
  • Figure 106: Koninklijke Philips NV Sales by Segments; 2023 (Percentage, %)
  • Figure 107: Siemens Healthineers AG Revenue by Segment; 2023 (Percentage, %)
  • Figure 108: DiaSorin Net Revenues by Segment; 2023 (Percentage, %)
  • Figure 109: Bruker Corporation Revenue by Segment; 2023 (Percentage, %)
  • Figure 110: T2 Biosystems, Inc. Revenue by Source; 2023 (Percentage, %)